Pemafibrate Improves Lipid and Liver Metabolism in Adult GH Deficiency: A Prospective Observational Study
Pemafibrate had beneficial effects on hypertriglyceridemia as well as liver metabolism of patients with AGHD. However, its efficacy was attenuated by obesity.
Authors
- SO NAGAI (ORCID: https://orcid.org/0000-0002-7372-8196)
- Hiroshi Iesaka (ORCID: https://orcid.org/0000-0002-1366-7555)
- Hiroyuki Kameda (ORCID: https://orcid.org/0000-0003-3667-4085)
- AIKA MIYA
- Akinobu Nakamura
- Kyu Yong Cho
- Tatsuya Atsumi
- Hiroshi Nomoto
Institutions
- Sapporo Medical University (JP)
- Asahikawa Medical University (JP)
- Health Sciences University of Hokkaido (JP)
- Hokkaido University (JP)
- NTT Medical Center (JP)
- Sapporo Science Center (JP)
- Hokkaido Institute of Public Health (JP)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1210/jendso/bvaf222
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00